title: Viability of long-term cryopreserved human saphenous veins.
abstract: The feasibility of maintaining long-term viability of human venous allografts by cryopreservation has been investigated. Segments of vein were obtained from 85 patients undergoing a stripping operation for varicose veins. The venous segments were immersed in a dimethylsulfoxide 15% solution, deep frozen at -196 degrees C in liquid nitrogen and preserved for a duration of 1 week to 24 months. Light microscopy (n = 126) failed to demonstrate striking differences between control veins and any of the cryopreserved veins. The types of damage observed at scanning electron microscopy included endothelial cell separation, endothelial cell loss, exposed basement membrane and exposed fibrillar collagen, which were graded on a scale. The score for short term (less than 3 weeks) stored veins was 8.1 +/- 0.9 (mean +/- SEM) and did not differ from the long-term (greater than 10 weeks) stored veins score (6.3 +/- 1.0, p NS). The tissue enzymes LDH, GOT, GPT, CPK were measured in the frozen vein groups (n = 115) after thawing to room temperature. Cryopreservation did not alter any of the tissue enzymes measured when compared to controls. Endothelial fibrinolytic activity (FA) of 58 venous segments cryopreserved for a mean duration of 20 months was 6136.4 +/- 292.1 Tissue Activator Units (TAU) and did not differ from FA of 11 controls (5989.1 +/- 696.8 TAU). Synthesis of 6-Keto-PGF1-alpha-2, a stable breakdown product of PGI2, measured in 10 venous segments cryopreserved for 10 months, was significantly higher than in 13 veins stored in saline for 12 hours at 4 degrees C (2.8 +/- 0.4 vs 0.4 +/- 0.1 PG ml-1mg-1min-1, respectively; p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Academic Hospital (UCL) of Mont-Godinne, Yvoir, Belgium.
authors.forename: Y A
authors.initials: YA
authors.lastname: Louagie
authors.forename: A
authors.initials: A
authors.lastname: Legrand-Monsieur
authors.forename: E
authors.initials: E
authors.lastname: Lavenne-Pardonge
authors.forename: C
authors.initials: C
authors.lastname: Remacle
authors.forename: P
authors.initials: P
authors.lastname: Delvaux
authors.forename: P
authors.initials: P
authors.lastname: Maldague
authors.forename: M
authors.initials: M
authors.lastname: Buche
authors.forename: R
authors.initials: R
authors.lastname: Ponlot
authors.forename: J C
authors.initials: JC
authors.lastname: Schoevaerdts
mesh_terms: D015925:Cryopreservation; D005260:Female; D006801:Humans; D008297:Male; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D011453:Prostaglandins / Q000096:biosynthesis; D012501:Saphenous Vein / Q000378:metabolism / Q000637:transplantation / Q000648:ultrastructure; D013997:Time Factors; D014021:Tissue Preservation
chemical_list: D011453:Prostaglandins